missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CD263 (TRAIL-R3) Synthetic Peptide
Click to view available options
Quantity:
50 μg
Unit Size:
50µg
Description
DcR1 Synthetic Peptide, PEP-0057, from Invitrogen.
TRAIL-R3 (CD263) is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain. This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis. This gene was found to be a p53-regulated DNA damage-inducible gene. The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL.
Specifications
Specifications
| Gene ID (Entrez) | 8794 |
| Species | Human |
| Purification Method | purified |
| Accession Number | O14798 |
| Common Name | Human CD263 (TRAIL-R3) |
| Concentration | 200 μg/mL |
| Content And Storage | -20°C |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formulation | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction